BioSpace News Archive

Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced that the Company’s fourth quarter 2020 financial results will be released on Tuesday, March 16, 2021.

Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial results for the year ended December 31, 2020 and provided an update on recent corporate developments.

CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that it will release financial results for the fiscal year and fourth quarter ended December 31, 2020, after the stock market closes on Thursday, March 18, 2021.

Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that Gerri Henwood, President and Chief Executive Officer, will participate in a fireside chat at the virtual Oppenheimer 31 st Annual Healthcare Conference on Thursday, March 18, 2021 at 9:20 a.m. ET.

2020 marked year of notable progress for Oncorus. Key highlights included: Transitioned to clinical-stage company with initiation of Phase 1 clinical trial of lead viral immunotherapy candidate, ONCR-177, for the treatment of solid tumors Announced clinical trial collaboration and supply agreement with Merck to evaluate combination of ONCR-177 with KEYTRUDA® (pembrolizumab)

Avid Bioservices, Inc. announced that its wholly-owned subsidiary, Avid SPV, LLC, has priced its sale of $125 million aggregate principal amount of exchangeable senior notes due 2026 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

Xenon Pharmaceuticals Inc., a clinical stage biopharmaceutical company, announced the pricing of its underwritten public offering of 4,324,325 common shares and, in lieu of common shares to a certain investor, pre-funded warrants to purchase up to 1,081,081 common shares pursuant to its existing shelf registration statement.

The global pharmaceutical logistics market involves a very complex operational process, which is essential as pharmaceuticals are an integral part of the health care industry.

Proper care before and after pregnancy is quite important. It can help the baby grow and develop, keeping both mother and baby safe and healthy.

Minimally invasive surgeries, which involve the use of endoscopes to view and intervene body organs through natural body orifice or small incisions, have witnessed tremendous advancement and adoption in the recent years.